Science
mRNA Cancer Vaccines Reach a Turning Point, But It's Too Early to Call Them a Cure
A personalized mRNA vaccine shows promise in Phase 3 melanoma trials, while a colorectal cancer trial was recently halted. We…
A personalized mRNA vaccine shows promise in Phase 3 melanoma trials, while a colorectal cancer trial was recently halted. We…
Read next